DEXCOM INC
DXCMNASDAQ🏆 #410 by market capEarnings Oct 22US Equity
$86.55▼ $0.13 (−0.15%)
LiveTrack DXCM
Get earnings, price moves & breaking news on Telegram
24h▼ 0.1%
7d▼ 3.3%
14d▲ 0.1%
30d▼ 4.7%
ytd▲ 30.4%
1y▲ 30.2%
🏦Market Cap
$32.66B
Mid Cap
📈Revenue Growth (YoY)
+15.6%
Healthy
📊Gross Margin
62.5%
High
💵FCF Margin
28.3%
Strong
⚖️P/S Ratio
6.6x
Fair
Otter Score
76
Good
DEXCOM INC
DXCMAnalyst Ratings
Price
$86.55
Total
52
Raised
12
Lowered
4
Avg PT
$90.36
H / L
$105 / $64
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
TD Cowen | Reiterated | Buy | 2026-09-18 | — | — |
Truist Securities | Reiterated | Buy | 2026-09-18 | — | — |
Argus Research | Reiterated | Buy | 2026-08-04 | $96.00 | +10.90% |
Canaccord Genuity | Reiterated | Buy | 2026-08-03 | $90.00 | +4.00% |
BTIG | Reiterated | Buy | 2026-07-31 | $90.00 | +4.00% |
Wells Fargo | Reiterated | Overweight | 2026-07-31 | $93.00 | +7.50% |
RBC Capital | Reiterated | Outperform | 2026-07-31 | $90.00 | +4.00% |
Citigroup | Reiterated | Buy | 2026-07-31 | $146.00 | +68.70% |
Stifel | Reiterated | Buy | 2026-07-31 | — | — |
Benchmark | Reiterated | Buy | 2026-07-31 | — | — |
Piper Sandler | Reiterated | Overweight | 2026-07-31 | $95.00 | +9.80% |
Mizuho | Reiterated | Outperform | 2026-07-31 | — | — |
JP Morgan | Reiterated | Neutral | 2026-07-31 | $450.00 | +419.90% |
Deutsche Bank | Reiterated | Buy | 2026-06-23 | $86.00 | −0.60% |
Barclays | Reiterated | Underweight | 2026-05-18 | $64.00 | −26.10% |
B of A Securities | Reiterated | Buy | 2026-05-18 | — | — |
Bernstein | Reiterated | Outperform | 2026-01-09 | $77.00 | −11.00% |
Morgan Stanley | Upgraded | Equal Weight → Overweight | 2025-12-02 | $75.00 | −13.30% |
UBS | Reiterated | Buy | 2025-11-03 | $96.00 | +10.90% |
Goldman Sachs | Reiterated | Buy | 2025-10-01 | — | — |
Baird | Reiterated | Outperform | 2025-09-26 | — | — |
Oppenheimer | Reiterated | Outperform | 2025-07-31 | $115.00 | +32.90% |
Raymond James | Reiterated | Strong Buy | 2025-07-31 | $94.00 | +8.60% |
Redburn Atlantic | Upgraded | Neutral → Buy | 2025-02-03 | — | — |
Leerink Partners | Reiterated | Outperform | 2024-10-25 | $92.00 | +6.30% |
Cowen & Co. | Reiterated | Outperform | 2023-02-10 | — | — |
SVB Leerink | Reiterated | Outperform | 2022-04-29 | — | — |
Guggenheim | Upgraded | Neutral → Buy | 2022-01-07 | — | — |
Stephens & Co. | Reiterated | Overweight | 2020-03-26 | — | — |
CFRA | Reiterated | Hold | 2020-02-14 | — | — |
Stifel Nicolaus | Reiterated | Buy | 2019-11-07 | $95.00 | +9.80% |
Piper Jaffray | Reiterated | Overweight | 2019-11-07 | — | — |
BMO Capital | Reiterated | Outperform | 2019-09-03 | — | — |
Bank of America | Reiterated | Buy | 2019-08-01 | — | — |
Northland Capital Markets | Upgraded | Underperform → Market Perform | 2018-09-12 | — | — |
Northland Securities | Upgraded | Underperform → Market Perform | 2018-09-12 | — | — |
Berenberg | Upgraded | Hold → Buy | 2018-08-06 | — | — |
Jefferies | Reiterated | Buy | 2018-08-02 | $655.00 | +656.80% |
B. Riley FBR | Upgraded | Neutral → Buy | 2018-05-05 | — | — |
BTIG Research | Downgraded | Buy → Neutral | 2017-05-03 | — | — |
B. Riley Securities | Upgraded | Neutral → Buy | 2016-12-15 | — | — |
Desjardins | Upgraded | Hold → Buy | 2016-09-16 | — | — |
Sterne Agee CRT | Upgraded | Neutral → Buy | 2015-10-15 | — | — |
Sterne Agee | Upgraded | Neutral → Buy | 2015-10-15 | — | — |
Leerink Swann | Upgraded | Market Perform → Outperform | 2015-10-15 | — | — |
Feltl & Co. | Downgraded | Hold → Sell | 2014-02-20 | — | — |
Wedbush | Reiterated | Outperform | 2013-11-07 | — | — |
Wunderlich Securities | Downgraded | Buy → Hold | 2013-06-10 | — | — |
Wunderlich | Downgraded | Buy → Hold | 2013-06-10 | — | — |
PiperJaffray | Reiterated | Overweight | 2012-09-20 | — | — |
McNicoll Lewis Vlak | Reiterated | Hold | 2012-05-03 | — | — |
Brean Capital | Reiterated | Buy | 2012-02-24 | — | — |
Institution
TD Cowen
Reiterated · Buy · 2026-09-18
—
—
Truist Securities
Reiterated · Buy · 2026-09-18
—
—
Argus Research
Reiterated · Buy · 2026-08-04
$96.00
+10.90%
Canaccord Genuity
Reiterated · Buy · 2026-08-03
$90.00
+4.00%
BTIG
Reiterated · Buy · 2026-07-31
$90.00
+4.00%
Wells Fargo
Reiterated · Overweight · 2026-07-31
$93.00
+7.50%
RBC Capital
Reiterated · Outperform · 2026-07-31
$90.00
+4.00%
Citigroup
Reiterated · Buy · 2026-07-31
$146.00
+68.70%
Stifel
Reiterated · Buy · 2026-07-31
—
—
Benchmark
Reiterated · Buy · 2026-07-31
—
—
Piper Sandler
Reiterated · Overweight · 2026-07-31
$95.00
+9.80%
Mizuho
Reiterated · Outperform · 2026-07-31
—
—
JP Morgan
Reiterated · Neutral · 2026-07-31
$450.00
+419.90%
Deutsche Bank
Reiterated · Buy · 2026-06-23
$86.00
−0.60%
Barclays
Reiterated · Underweight · 2026-05-18
$64.00
−26.10%
B of A Securities
Reiterated · Buy · 2026-05-18
—
—
Bernstein
Reiterated · Outperform · 2026-01-09
$77.00
−11.00%
Morgan Stanley
Upgraded · Equal Weight → Overweight · 2025-12-02
$75.00
−13.30%
UBS
Reiterated · Buy · 2025-11-03
$96.00
+10.90%
Goldman Sachs
Reiterated · Buy · 2025-10-01
—
—
Baird
Reiterated · Outperform · 2025-09-26
—
—
Oppenheimer
Reiterated · Outperform · 2025-07-31
$115.00
+32.90%
Raymond James
Reiterated · Strong Buy · 2025-07-31
$94.00
+8.60%
Redburn Atlantic
Upgraded · Neutral → Buy · 2025-02-03
—
—
Leerink Partners
Reiterated · Outperform · 2024-10-25
$92.00
+6.30%
Cowen & Co.
Reiterated · Outperform · 2023-02-10
—
—
SVB Leerink
Reiterated · Outperform · 2022-04-29
—
—
Guggenheim
Upgraded · Neutral → Buy · 2022-01-07
—
—
Stephens & Co.
Reiterated · Overweight · 2020-03-26
—
—
CFRA
Reiterated · Hold · 2020-02-14
—
—
Stifel Nicolaus
Reiterated · Buy · 2019-11-07
$95.00
+9.80%
Piper Jaffray
Reiterated · Overweight · 2019-11-07
—
—
BMO Capital
Reiterated · Outperform · 2019-09-03
—
—
Bank of America
Reiterated · Buy · 2019-08-01
—
—
Northland Capital Markets
Upgraded · Underperform → Market Perform · 2018-09-12
—
—
Northland Securities
Upgraded · Underperform → Market Perform · 2018-09-12
—
—
Berenberg
Upgraded · Hold → Buy · 2018-08-06
—
—
Jefferies
Reiterated · Buy · 2018-08-02
$655.00
+656.80%
B. Riley FBR
Upgraded · Neutral → Buy · 2018-05-05
—
—
BTIG Research
Downgraded · Buy → Neutral · 2017-05-03
—
—
B. Riley Securities
Upgraded · Neutral → Buy · 2016-12-15
—
—
Desjardins
Upgraded · Hold → Buy · 2016-09-16
—
—
Sterne Agee CRT
Upgraded · Neutral → Buy · 2015-10-15
—
—
Sterne Agee
Upgraded · Neutral → Buy · 2015-10-15
—
—
Leerink Swann
Upgraded · Market Perform → Outperform · 2015-10-15
—
—
Feltl & Co.
Downgraded · Hold → Sell · 2014-02-20
—
—
Wedbush
Reiterated · Outperform · 2013-11-07
—
—
Wunderlich Securities
Downgraded · Buy → Hold · 2013-06-10
—
—
Wunderlich
Downgraded · Buy → Hold · 2013-06-10
—
—
PiperJaffray
Reiterated · Overweight · 2012-09-20
—
—
McNicoll Lewis Vlak
Reiterated · Hold · 2012-05-03
—
—
Brean Capital
Reiterated · Buy · 2012-02-24
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space